New study tracks hidden sugar damage in patients on IV nutrition
NCT ID NCT07392801
First seen Feb 06, 2026 · Last updated Jun 22, 2026 · Updated 27 times
Summary
This study will follow 50 adults and children who are starting long-term parenteral nutrition (IV nutrition) to measure the buildup of advanced glycation end-products (AGEs) in their skin. AGEs are harmful compounds that form when sugar binds to proteins, and they may increase health risks. Researchers will use a non-invasive skin device to track AGE levels over 12 months and look for links to diet and metabolism.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARENTERAL NUTRITION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AP-HP - Hopital Robert Debré
Paris, 75935, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Bordeaux - Hôpital Haut Lévêque
Pessac, 33600, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Bordeaux-Hôpital des enfants GH Pellegrin
Bordeaux, 33076, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help identify risk factors for complications in patients on long-term parenteral nutrition, leading to better monitoring and dietary adjustments.
What could go wrong
This is a small observational study (50 people) that only measures a biomarker, not a treatment. It may not lead to direct clinical changes, and results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.